• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Bloodstream infections caused by Entero-bacteriaceae in China.

作者信息

Zheng Beiwen, Chen Yunbo, Violetta Laurencia, Xiao Yonghong, Li Lanjuan

机构信息

Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

出版信息

Lancet Infect Dis. 2019 Aug;19(8):810-811. doi: 10.1016/S1473-3099(19)30352-4.

DOI:10.1016/S1473-3099(19)30352-4
PMID:31345454
Abstract
摘要

相似文献

1
Bloodstream infections caused by Entero-bacteriaceae in China.
Lancet Infect Dis. 2019 Aug;19(8):810-811. doi: 10.1016/S1473-3099(19)30352-4.
2
Bloodstream infections and carbapenem-resistant Enterobacteriaceae in South Korea.韩国的血流感染与耐碳青霉烯类肠杆菌科细菌
Lancet Infect Dis. 2019 Sep;19(9):931-932. doi: 10.1016/S1473-3099(19)30431-1.
3
Carbapenem-resistant Enterobacteriaceae: global action required.耐碳青霉烯类肠杆菌科细菌：需要全球行动。
Lancet Infect Dis. 2019 Jun;19(6):561-562. doi: 10.1016/S1473-3099(19)30210-5. Epub 2019 Apr 29.
4
EUropean prospective cohort study on showing REsistance to CArbapenems (EURECA): a protocol of a European multicentre observational study.EUropean 前瞻性队列研究显示对碳青霉烯类抗生素的耐药性（EURECA）：一项欧洲多中心观察性研究的方案。
BMJ Open. 2017 Apr 3;7(4):e015365. doi: 10.1136/bmjopen-2016-015365.
5
The need for adequate research data on carbapenem use and resistance in Bangladesh.孟加拉国对碳青霉烯类药物使用及耐药性充分研究数据的需求。
Lancet Infect Dis. 2019 Aug;19(8):811. doi: 10.1016/S1473-3099(19)30353-6.
6
Comparison of empirical therapy with cefoperazone/sulbactam or a carbapenem for bloodstream infections due to ESBL-producing Enterobacteriaceae.产 ESBL 肠杆菌科细菌血流感染的头孢哌酮/舒巴坦与碳青霉烯类经验性治疗的比较。
J Antimicrob Chemother. 2018 Nov 1;73(11):3176-3180. doi: 10.1093/jac/dky323.
7
Cefmetazole for bacteremia caused by ESBL-producing enterobacteriaceae comparing with carbapenems.头孢美唑用于治疗产超广谱β-内酰胺酶肠杆菌科细菌所致菌血症并与碳青霉烯类药物比较
BMC Infect Dis. 2016 Aug 18;16(1):427. doi: 10.1186/s12879-016-1770-1.
8
Carbapenems Versus Piperacillin-Tazobactam for Bloodstream Infections of Nonurinary Source Caused by Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae.碳青霉烯类药物与哌拉西林-他唑巴坦治疗产超广谱β-内酰胺酶肠杆菌科细菌引起的非泌尿道来源血流感染的疗效比较
Infect Control Hosp Epidemiol. 2015 Aug;36(8):981-5. doi: 10.1017/ice.2015.101. Epub 2015 May 20.
9
Enterobacteriaceae bacteremia: risk factors for ESBLPE.肠杆菌科菌血症：产 ESBLPE 的危险因素。
Med Mal Infect. 2014 Jan;44(1):32-8. doi: 10.1016/j.medmal.2013.11.003. Epub 2013 Dec 8.
10
[Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].[2011年、2013年和2016年医院获得性菌血症病原菌的微生物学特征]
Sheng Wu Gong Cheng Xue Bao. 2018 Aug 25;34(8):1205-1217. doi: 10.13345/j.cjb.180192.

引用本文的文献

1
Analysis of clinical characteristics of patients with coronavirus disease 2019 based on a superior carbapenem-resistant Enterobacterales identification strategy.基于一种高级耐碳青霉烯类肠杆菌鉴定策略的2019冠状病毒病患者临床特征分析
Medicine (Baltimore). 2025 Jun 27;104(26):e43046. doi: 10.1097/MD.0000000000043046.
2
Trends in Antibiotic Resistance Patterns and Burden of Escherichia Coli Infections in Young Children: A Retrospective Cross-Sectional Study in Shenzhen, China from 2014-2018.幼儿大肠埃希菌感染的抗生素耐药模式及负担趋势：2014 - 2018年中国深圳的一项回顾性横断面研究
Infect Drug Resist. 2023 Aug 21;16:5501-5510. doi: 10.2147/IDR.S425728. eCollection 2023.
3
Epidemiology and Risk Factors of Community-Associated Bloodstream Infections in Zhejiang Province, China, 2017-2020.
2017 - 2020年中国浙江省社区获得性血流感染的流行病学及危险因素
Infect Drug Resist. 2023 Mar 18;16:1579-1590. doi: 10.2147/IDR.S400108. eCollection 2023.
4
First report of co-producing OXA-181, CTX-M-55, and MCR-8 isolated from the patient with bacteremia.首例从菌血症患者中分离出同时产OXA-181、CTX-M-55和MCR-8的报告。
Front Microbiol. 2022 Oct 14;13:1020500. doi: 10.3389/fmicb.2022.1020500. eCollection 2022.
5
Emergence of Neonatal Sepsis Caused by MCR-9- and NDM-1-Co-Producing in China.中国出现产超广谱β-内酰胺酶和新德里金属β-内酰胺酶 1 共同介导的新生儿败血症。
Front Cell Infect Microbiol. 2022 May 6;12:879409. doi: 10.3389/fcimb.2022.879409. eCollection 2022.
6
Evaluation of the EUCAST Rapid Antimicrobial Susceptibility Test for -Containing Blood Cultures in China.中国评估 EUCAST 快速抗微生物药敏试验在含碳青霉烯类药物血培养物中的应用。
J Clin Microbiol. 2022 Apr 20;60(4):e0255921. doi: 10.1128/jcm.02559-21. Epub 2022 Mar 31.
7
Blood bacterial resistant investigation collaborative system (BRICS) report: a national surveillance in China from 2014 to 2019.血培养细菌耐药监测协作组（BRICS）报告：2014 年至 2019 年中国全国监测。
Antimicrob Resist Infect Control. 2022 Jan 24;11(1):17. doi: 10.1186/s13756-022-01055-5.
8
The genetic feature and virulence determinant of highly virulent community-associated MRSA ST338-SCCmec Vb in China.中国高毒力社区获得性耐甲氧西林金黄色葡萄球菌ST338-SCCmec Vb的遗传特征及毒力决定因素
Emerg Microbes Infect. 2021 Dec;10(1):1052-1064. doi: 10.1080/22221751.2021.1914516.